Semin Respir Crit Care Med 2004; 25(4): 413-423
DOI: 10.1055/s-2004-832714
Copyright © 2004 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Role of Flexible Bronchoscopy in Lung Transplantation

Prashant N. Chhajed1 , 2 , 3 , Michael Tamm1 , 3 , Allan R. Glanville2
  • 1Division of Respiratory Medicine and Pulmonary Cell Research, University Hospital Basel, Basel, Switzerland
  • 2The Lung Transplant Unit, St. Vincent’s Hospital, Sydney, Australia
  • 3Institute of Pulmonology, Medical Research and Development, Mumbai, India
Further Information

Publication History

Publication Date:
30 August 2004 (online)

Flexible bronchoscopy with bronchoalveolar lavage and transbronchial biopsy has contributed significantly to the success of lung transplantation to detect rejection and infections (bacterial, fungal, viral, and protozoal). It permits the visualization of the airway anastomosis and also allows for the management of airway complications using interventional bronchoscopic techniques such as balloon dilatation, stent insertion, and laser. A new classification (TEGLA [thickness, extent of injury, granulation tissue, loose sutures, anastomotic complications]) for uniform reporting of airway ischemic injury is proposed. The common complications during flexible bronchoscopy include acute hypoxemia, bleeding, and pneumothorax. The management of these complications during flexible bronchoscopy and the value of surveillance and follow-up transbronchial biopsy and bronchoalveolar lavage is discussed. Bronchoalveolar lavage and transbronchial biopsy are also used for research purposes and might hopefully allow recognition of bronchiolitis obliterans at an earlier stage.

REFERENCES

  • 1 Baldwin J C, Oyer P E, Stinson E B et al.. Comparison of cardiac rejection in heart and heart-lung transplantation.  J Heart Transplant. 1987;  6 352-356
  • 2 Rhenman B, Rhenman M J, Icenogle T B et al.. Heart-lung transplantation: the initial Arizona experience.  J Thorac Cardiovasc Surg. 1989;  98(5 Pt 2) 922-927
  • 3 Glanville A R, Imoto E, Baldwin J C et al.. The role of right ventricular endomyocardial biopsy in the long-term management of heart-lung transplant recipients.  J Heart Transplant. 1987;  6 357-361
  • 4 Higenbottam T, Hutter J A, Stewart S, Wallwork J. Transbronchial biopsy has eliminated the need for endomyocardial biopsy in heart-lung recipients.  J Heart Transplant. 1988;  7 435-439
  • 5 Husain A N, Siddiqui M T, Montoya A, Chandrasekhar A J, Garrity E R. Post-lung transplant biopsies: an 8-year Loyola experience.  Mod Pathol. 1996;  9 126-132
  • 6 Higenbottam T, Stewart S, Penketh A, Wallwork J. Transbronchial lung biopsy for the diagnosis of rejection in heart-lung transplant patients.  Transplantation. 1988;  46 532-539
  • 7 Yousem S A, Berry G J, Cagle P T et al.. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group.  J Heart Lung Transplant. 1996;  15(1 Pt 1) 1-15
  • 8 Trulock E P, Ettinger N A, Brunt E M et al.. The role of transbronchial lung biopsy in the treatment of lung transplant recipients: an analysis of 200 consecutive procedures.  Chest. 1992;  102 1049-1054
  • 9 Sibley R K, Berry G J, Tazelaar H D et al.. The role of transbronchial biopsies in the management of lung transplant recipients.  J Heart Lung Transplant. 1993;  12 308-324
  • 10 Hopkins P M, Aboyoun C L, Chhajed P N et al.. Prospective analysis of 1,235 transbronchial lung biopsies in lung transplant recipients.  J Heart Lung Transplant. 2002;  21 1062-1067
  • 11 British Thoracic Society guidelines on diagnostic flexible bronchoscopy.  Thorax. 2001;  56(Suppl 1) i1-21
  • 12 Pearce S J. Fibreoptic bronchoscopy: is sedation necessary?.  BMJ. 1980;  281 779-780
  • 13 Colt H G, Morris J F. Fiberoptic bronchoscopy without premedication: a retrospective study.  Chest. 1990;  98 1327-1330
  • 14 Simpson F G, Arnold A G, Purvis A et al.. Postal survey of bronchoscopic practice by physicians in the United Kingdom.  Thorax. 1986;  41 311-317
  • 15 Prakash U B, Offord K P, Stubbs S E. Bronchoscopy in North America: the ACCP survey.  Chest. 1991;  100 1668-1675
  • 16 Reed A P. Preparation of the patient for awake flexible fiberoptic bronchoscopy.  Chest. 1992;  101 244-253
  • 17 Rees P J, Hay J G, Webb J R. Premedication for fibreoptic bronchoscopy.  Thorax. 1983;  38 624-627
  • 18 Macfarlane J T, Storr A, Wart M J, Smith W H. Safety, usefulness and acceptability of fibreoptic bronchoscopy in the elderly.  Age Ageing. 1981;  10 127-131
  • 19 Williams T J, Nicoulet I, Coleman E, McAlaney C. Safety and patient acceptability of intravenous midazolam for fibre optic bronchoscopy.  Respir Med. 1994;  88 305-307
  • 20 Chhajed P N, Aboyoun C L, Malouf M A et al.. Progressive increase in sedative drug requirements for flexible bronchoscopy in lung transplant recipients.  Am J Respir Crit Care Med. 2003;  167 A529
  • 21 Chhajed P N, Cooper P. Pediatric flexible bronchoscopy.  Indian Pediatr. 2001;  38 1382-1392
  • 22 Chhajed P N, Aboyoun C, Malouf M A et al.. Management of acute hypoxemia during flexible bronchoscopy with insertion of a nasopharyngeal tube in lung transplant recipients.  Chest. 2002;  121 1350-1354
  • 23 Chhajed P N, Tamm M, Malouf M A, Glanville A R. Lung transplantation: management and complications.  Indian J Chest Dis Allied Sci. 2002;  44 31-43
  • 24 Snell G I, Ward C, Wilson J W et al.. Immunopathological changes in the airways of stable lung transplant recipients.  Thorax. 1997;  52 322-328
  • 25 Heurlin N, Markling L, Barkholt L et al.. Rapid detection of cytomegalovirus antigen on alveolar cells in bronchoalveolar fluid from transplant patients with cytomegalovirus pneumonia.  Clin Transplant. 1994;  8 466-473
  • 26 Tiroke A H, Bewig B, Haverich A. Bronchoalveolar lavage in lung transplantation: state of the art.  Clin Transplant. 1999;  13 131-157
  • 27 Zavala D C. Pulmonary hemorrhage in fiberoptic transbronchial biopsy.  Chest. 1976;  70 584-588
  • 28 Chhajed P N, Aboyoun C, Malouf M A et al.. Risk factors and management of bleeding associated with transbronchial lung biopsy in lung transplant recipients.  J Heart Lung Transplant. 2003;  22 195-197
  • 29 Scott J P, Fradet G, Smyth R L et al.. Prospective study of transbronchial biopsies in the management of heart-lung and single lung transplant patients. J Heart Lung Transplant. 1991 10(5 Pt 1): 626-636 discussion 636-627
  • 30 Chhajed P N, Malouf M A, Glanville A R. Bronchoscopic dilatation in the management of benign (non-transplant) tracheobronchial stenosis.  Intern Med J. 2001;  31 512-516
  • 31 Sheski F D, Mathur P N. Long-term results of fiberoptic bronchoscopic balloon dilation in the management of benign tracheobronchial stenosis.  Chest. 1998;  114 796-800
  • 32 Davies D G, Parsek M R, Pearson J P et al.. The involvement of cell-to-cell signals in the development of a bacterial biofilm.  Science. 1998;  280 295-298
  • 33 Kolter R, Losick R. One for all and all for one.  Science. 1998;  280 226-227
  • 34 Seballos R J, Mehta A C. Care and maintenence of the flexible bronchoscope. In: Wang KMA Flexible Bronchoscopy Boston, MA; Blackwell 1995: 81-92
  • 35 Culver D A, Gordon S M, Mehta A C. Infection control in the bronchoscopy suite: a review of outbreaks and guidelines for prevention.  Am J Respir Crit Care Med. 2003;  167 1050-1056
  • 36 Rutala W A, Gergen M F, Weber D J. Comparative evaluation of the sporicidal activity of new low-temperature sterilization technologies: ethylene oxide, 2 plasma sterilization systems, and liquid peracetic acid.  Am J Infect Control. 1998;  26 393-398
  • 37 Muscarella L F. Deja vu … all over again? The importance of instrument drying.  Infect Control Hosp Epidemiol. 2000;  21 628-629
  • 38 Kirschke D L, Jones T F, Craig A S et al.. Pseudomonas aeruginosa and Serratia marcescens contamination associated with a manufacturing defect in bronchoscopes.  N Engl J Med. 2003;  348 214-220
  • 39 Pereira Jr W, Kovnat D M, Snider G L. A prospective cooperative study of complications following flexible fiberoptic bronchoscopy.  Chest. 1978;  73 813-816
  • 40 Credle Jr W F, Smiddy J F, Elliott R C. Complications of fiberoptic bronchoscopy.  Am Rev Respir Dis. 1974;  109 67-72
  • 41 Langmack E L, Martin R J, Pak J, Kraft M. Serum lidocaine concentrations in asthmatics undergoing research bronchoscopy.  Chest. 2000;  117 1055-1060
  • 42 Chhajed P N, Aboyoun C L, Malouf M A et al.. Prophylactic nasopharyngeal tube insertion prevents acute hypoxemia due to upper airway obstruction during flexible bronchoscopy. Intern Med J.  2003;  33(7) 317-318
  • 43 Chhajed P N, Glanville A R. Management of hypoxemia during flexible bronchoscopy.  Clin Chest Med. 2003;  24 511-516
  • 44 Diette G B, Wiener C M, White Jr P. The higher risk of bleeding in lung transplant recipients from bronchoscopy is independent of traditional bleeding risks: results of a prospective cohort study.  Chest. 1999;  115 397-402
  • 45 Cordasco Jr E M, Mehta A C, Ahmad M. Bronchoscopically induced bleeding: a summary of nine years’ Cleveland clinic experience and review of the literature.  Chest. 1991;  100 1141-1147
  • 46 Prakash U B, Utz J P. Bronchoscopic lung biopsy. In: Wang KP, Mehta AC Flexible Bronchoscopy London; Blackwell 1995: 119-135
  • 47 Breuer H W, Charchut S, Worth H, Trampisch H J, Glanzer K. Endobronchial versus intravenous application of the vasopressin derivative glypressin during diagnostic bronchoscopy.  Eur Respir J. 1989;  2 225-228
  • 48 Barman S A, Ardell J L, Parker J C, Perry M L, Taylor A E. Pulmonary and systemic blood flow contributions to upper airways in canine lung.  Am J Physiol. 1988;  255(5 Pt 2) H1130-H1135
  • 49 Magno M. Comparative anatomy of the tracheobronchial circulation.  Eur Respir J Suppl. 1990;  12 557s-562s , discussion 562s-563s
  • 50 Shennib H, Massard G. Airway complications in lung transplantation.  Ann Thorac Surg. 1994;  57 506-511
  • 51 Couraud L, Nashef S AM, Nicolini P, Jougon J. Classification of airway anastomotic healing.  Eur J Cardiothorac Surg. 1992;  6 496-497
  • 52 Malouf M A, Glanville A R. The spectrum of mycobacterial infection after lung transplantation.  Am J Respir Crit Care Med. 1999;  160(5 Pt 1) 1611-1616
  • 53 Tamm M, Malouf M, Glanville A. Pulmonary Scedosporium infection following lung transplantation.  Transpl Infect Dis. 2001;  3 189-194
  • 54 Yousem S A. Graft eosinophilia in lung transplantation.  Hum Pathol. 1992;  23 1172-1177
  • 55 Nunley D R, Grgurich W, Iacono A T et al.. Allograft colonization and infections with Pseudomonas in cystic fibrosis lung transplant recipients.  Chest. 1998;  113 1235-1243
  • 56 Kramer M R, Stoehr C, Lewiston N J, Starnes V A, Theodore J. Trimethoprim-sulfamethoxazole prophylaxis for Pneumocystis carinii infections in heart-lung and lung transplantation: how effective and for how long?.  Transplantation. 1992;  53 586-589
  • 57 Miller R F, Le Noury J, Corbett E L, Felton J M, De Cock K M. Pneumocystis carinii infection: current treatment and prevention.  J Antimicrob Chemother. 1996;  37(suppl B) 33-53
  • 58 Cahill B C, Hibbs J R, Savik K et al.. Aspergillus airway colonization and invasive disease after lung transplantation.  Chest. 1997;  112 1160-1164
  • 59 Nunley D R, Ohori P, Grgurich W F et al.. Pulmonary aspergillosis in cystic fibrosis lung transplant recipients.  Chest. 1998;  114 1321-1329
  • 60 Helmi M, Love R B, Welter D, Cornwell R D, Meyer K C. Aspergillus infection in lung transplant recipients with cystic fibrosis: risk factors and outcomes comparison to other types of transplant recipients.  Chest. 2003;  123 800-808
  • 61 Stephan F, Bernaudin J F, Cesari D et al.. Blood and alveolar lymphocyte subsets in pulmonary cytomegalovirus infection after lung transplantation.  BMC Infect Dis. 2001;  1 15
  • 62 Riise G C, Kjellstrom C, Ryd W et al.. Inflammatory cells and activation markers in BAL during acute rejection and infection in lung transplant recipients: a prospective, longitudinal study.  Eur Respir J. 1997;  10 1742-1746
  • 63 Bewig B, Haacke T C, Tiroke A et al.. Detection of CMV pneumonitis after lung transplantation using PCR of DNA from bronchoalveolar lavage cells.  Respiration. 2000;  67 166-172
  • 64 Boehler A, Vogt P, Zollinger A, Weder W, Speich R. Prospective study of the value of transbronchial lung biopsy after lung transplantation.  Eur Respir J. 1996;  9 658-662
  • 65 Kesten S, Chamberlain D, Maurer J. Yield of surveillance transbronchial biopsies performed beyond two years after lung transplantation.  J Heart Lung Transplant. 1996;  15 384-388
  • 66 Valentine V G, Taylor D E, Dhillon G S et al.. Success of lung transplantation without surveillance bronchoscopy.  J Heart Lung Transplant. 2002;  21 319-326
  • 67 Tamm M, Sharples L D, Higenbottam T W, Stewart S, Wallwork J. Bronchiolitis obliterans syndrome in heart-lung transplantation: surveillance biopsies.  Am J Respir Crit Care Med. 1997;  155 1705-1710
  • 68 Baz M A, Layish D T, Govert J A et al.. Diagnostic yield of bronchoscopies after isolated lung transplantation.  Chest. 1996;  110 84-88
  • 69 Aboyoun C L, Tamm M, Chhajed P N et al.. Diagnostic value of follow-up transbronchial lung biopsy after lung rejection.  Am J Respir Crit Care Med. 2001;  164 460-463
  • 70 Pomerance A, Madden B, Burke M M, Yacoub M H. Transbronchial biopsy in heart and lung transplantation: clinicopathologic correlations.  J Heart Lung Transplant. 1995;  14 761-773
  • 71 Chamberlain D, Maurer J, Chaparro C, Idolor L. Evaluation of transbronchial lung biopsy specimens in the diagnosis of bronchiolitis obliterans after lung transplantation.  J Heart Lung Transplant. 1994;  13 963-971
  • 72 Collins J, Hartman M J, Warner T F et al.. Frequency and CT findings of recurrent disease after lung transplantation.  Radiology. 2001;  219 503-509
  • 73 Gabbay E, Dark J H, Ashcroft T et al.. Recurrence of Langerhans' cell granulomatosis following lung transplantation.  Thorax. 1998;  53 326-327
  • 74 Habib S B, Congleton J, Carr D et al.. Recurrence of recipient Langerhans’ cell histiocytosis following bilateral lung transplantation.  Thorax. 1998;  53 323-325
  • 75 Chhajed P N, Malouf M A, Tamm M, Spratt P, Glanville A R. Interventional bronchoscopy for the management of airway complications following lung transplantation.  Chest. 2001;  120 1894-1899
  • 76 Griffith B P, Hardesty R L, Armitage J M et al.. A decade of lung transplantation.  Ann Surg. 1993;  218 310-318 , discussion 318-320
  • 77 Schafers H J, Haydock D A, Cooper J D. The prevalence and management of bronchial anastomotic complications in lung transplantation.  J Thorac Cardiovasc Surg. 1991;  101 1044-1052
  • 78 Schmid R A, Boehler A, Speich R et al.. Bronchial anastomotic complications following lung transplantation: still a major cause of morbidity.  Eur Respir J. 1997;  10 2872-2875
  • 79 Carre P, Rousseau H, Lombart L et al.. Balloon dilatation and self-expanding metal Wallstent insertion: for management of bronchostenosis following lung transplantation. The Toulouse Lung Transplantation Group.  Chest. 1994;  105 343-348
  • 80 Kshettry V R, Kroshus T J, Hertz M I et al.. Early and late airway complications after lung transplantation: incidence and management.  Ann Thorac Surg. 1997;  63 1576-1583
  • 81 Brichon P Y, Blanc-Jouvan F, Rousseau H et al.. Endovascular stents for bronchial stenosis after lung transplantation.  Transplant Proc. 1992;  24 2656-2659
  • 82 Vinograd I, Klin B, Brosh T et al.. A new intratracheal stent made from nitinol, an alloy with “shape memory effect”.  J Thorac Cardiovasc Surg. 1994;  107 1255-1261
  • 83 Williams D F. Titanium as a metal for implantation, II: Biological properties and clinical applications.  J Med Eng Technol. 1977;  1 266-270
  • 84 Chhajed P N, Malouf M A, Tamm M, Glanville A R. Ultraflex stents for the management of airway complications in lung transplant recipients.  Respirology. 2003;  8 59-64
  • 85 Tamm M, Roth M, Malouf M et al.. Primary fibroblast cell cultures from transbronchial biopsies of lung transplant recipients.  Transplantation. 2001;  71 337-339
  • 86 Azzola A, Havryk A, Chhajed P N et al.. Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation.  Transplantation. 2004;  77 275-280
  • 87 Bergmann M, Tiroke A, Schafer H, Barth J, Haverich A. Gene expression of profibrotic mediators in bronchiolitis obliterans syndrome after lung transplantation.  Scand Cardiovasc J. 1998;  32 97-103
  • 88 Scholma J, Slebos D J, Boezen H M et al.. Eosinophilic granulocytes and interleukin-6 level in bronchoalveolar lavage fluid are associated with the development of obliterative bronchiolitis after lung transplantation.  Am J Respir Crit Care Med. 2000;  162 2221-2225
  • 89 Havryk A, Azzola A, Chhajed P N et al.. Matrix metalloproteinase profile in bronchoalveolar lavage fluid in posttransplant obliterative bronchiolitis.  Am J Respir Crit Care Med. 2002;  165 A396

Prashant N ChhajedM.D. 

Division of Respiratory Medicine and Pulmonary Cell Research, University Hospital Basel

Petersgraben 4, CH-4031, Basel, Switzerland

Email: chhajed@hotmail.com